CMS RBCS · Treatments · Radiation Oncology

Radiation Oncology — codes without an RBCS family

15 CPT®/HCPCS codes, ranked by est. all-Medicare services — scaled from national Medicare Part B fee-for-service volume. Open any code for the full market view — ranked physician groups, geography, and 12-year trend.

CMS's RBCS classification leaves these codes at the subcategory level — no family is assigned. We list them; we don't invent a family.

CY2024 · National scale is an all-Medicare estimate · est. — scaled estimate — assumes MA utilization mirrors FFS; not an observation; the observed fee-for-service figure is shown adjacent. Part B · national figures

HCPCS · Radiation Oncology treatment A9607 Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie CMS descriptor · HCPCS
Medicare Part B claims

First observed 2022 — first year this code appears in Part B claims

National scale 587,141 services · est. ▼ 29.2% YoY · 592 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 301,011 observed fee-for-service services

See the national market for A9607 → ranked groups · states · 12-yr trend

HCPCS · Radiation Oncology treatment A9517 Iodine i-131 sodium iodide capsule(s), therapeutic, per millicurie CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 3,200 services · est. ▲ 350.5% YoY · 29 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 1,596 observed fee-for-service services

See the national market for A9517 → ranked groups · states · 12-yr trend

13 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.